1 enrolling by invitation. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow exemestane: new trials by email Literature Review of exemestane trials Research Report on exemestane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study TOL2506, Tamoxifen, Letrozole tablets - Breast Cancer | Phase 3 | Enrolling by invitation | Tolmar Inc. | 250 | 2022-12-28 | 2026-10-23 |
Breast Neoplasms (1) · Neoplasms (1)
Tolmar Inc. (1)
Argentina (1) · Brazil (1) · India (1) · Mexico (1) · Puerto Rico (1) · United States (1)